Trials / Conditions / Bladder Urothelial Cancer
Bladder Urothelial Cancer
3 registered clinical trials studyying Bladder Urothelial Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors NCT05311618 | NGM Biopharmaceuticals, Inc | Phase 1 |
| Active Not Recruiting | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced o NCT05215574 | NGM Biopharmaceuticals, Inc | Phase 1 |
| Unknown | An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer NCT04492293 | Beijing InnoCare Pharma Tech Co., Ltd. | Phase 2 |